Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about ATG3: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
ATG3 is a gene implicated in neurodegeneration research. Key relationships include: regulates, activates, associated with. Associated with Aging, Als, Amyotrophic Lateral Sclerosis. Connected to 190 entities in the SciDEX knowledge graph.
No AI portrait yet
| Gene Symbol | ATG3 |
| Full Name | Autophagy Related 3 |
| Chromosome | 3q13.11 |
| Function | is an essential autophagy gene encoding a ubiquitin-like conjugating enzyme that plays a critical role in autophagosome formation[@mizushima2011]. |
| Molecular Weight | ~35 kDa |
| Amino Acids | 314 amino acids |
| Exons | 12 |
| Pathways | Apoptosis, Autophagy, Car-T, Immunotherapy, Tdp-43 |
| GeneCards | ATG3 |
| Human Protein Atlas | ATG3 |
| Associated Diseases | ALS, Inflammation, Ms, Osteoarthritis, Rheumatoid Arthritis |
| Interactions | ACHE, AGING, AND, APOPTOSIS, ARAF, ATG12 |
| KG Connections | 248 knowledge graph edges |
| Databases | GeneCardsUniProtNCBI GeneHPASTRING |
Knowledge base pages for this entity
graph TD
ATG3["ATG3"] -->|"protects against"| CD19_CAR_T_cell_cytotoxicity["CD19 CAR-T cell cytotoxicity"]
ATG3["ATG3"] -->|"therapeutic target"| Amyotrophic_Lateral_Sclerosis["Amyotrophic Lateral Sclerosis"]
ATG3["ATG3"] -->|"therapeutic target"| Als["Als"]
ATG3["ATG3"] -->|"activates"| Cancer["Cancer"]
ATG3["ATG3"] -->|"regulates"| Leukemia["Leukemia"]
ATG3["ATG3"] -->|"regulates"| Cancer_1["Cancer"]
CAT["CAT"] -->|"therapeutic target"| ATG3["ATG3"]
ATG4B["ATG4B"] -->|"therapeutic target"| ATG3["ATG3"]
TARDBP["TARDBP"] -->|"therapeutic target"| ATG3["ATG3"]
ATG13["ATG13"] -->|"contributes to"| ATG3["ATG3"]
style ATG3 fill:#4a1a6b,stroke:#4fc3f7,stroke-width:2px,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| CD19 CAR-T cell cytotoxicity | protects_against | phenotype | 0.90 |
| Ferroptosis | contributes_to | process | 0.85 |
| autophagy pathway | participates_in | pathway | 0.80 |
| ATG7 | inhibits | gene | 0.70 |
| Autophagy | expressed_in | pathway | 0.70 |
| Autophagy | regulates | pathway | 0.70 |
| Als | regulates | disease | 0.65 |
| Inflammation | associated_with | disease | 0.65 |
| Tumor | expressed_in | disease | 0.65 |
| Neurodegeneration | expressed_in | disease | 0.65 |
| Als | activates | disease | 0.65 |
| Ms | associated_with | disease | 0.65 |
| Ms | regulates | disease | 0.65 |
| Amyotrophic Lateral Sclerosis | therapeutic_target | disease | 0.65 |
| Osteoarthritis | associated_with | disease | 0.65 |
| Lymphoma | regulates | disease | 0.65 |
| Tumor | regulates | disease | 0.65 |
| Als | inhibits | disease | 0.65 |
| Pain | therapeutic_target | disease | 0.65 |
| Ms | activates | disease | 0.65 |
| Rheumatoid Arthritis | associated_with | disease | 0.65 |
| Als | expressed_in | disease | 0.65 |
| Cancer | activates | disease | 0.65 |
| Leukemia | regulates | disease | 0.65 |
| Amyotrophic Lateral Sclerosis | regulates | disease | 0.65 |
| Amyotrophic Lateral Sclerosis | inhibits | disease | 0.65 |
| Aging | inhibits | disease | 0.65 |
| Als | therapeutic_target | disease | 0.65 |
| Cancer | regulates | disease | 0.65 |
| FERROPTOSIS | contributes_to | phenotype | 0.64 |
| BECN1 | associated_with | gene | 0.60 |
| ATG7 | associated_with | gene | 0.60 |
| NEURON | therapeutic_target | gene | 0.60 |
| LC3B | associated_with | gene | 0.60 |
| ALS | associated_with | disease | 0.60 |
| APOPTOSIS | activates | gene | 0.60 |
| MITOPHAGY | activates | gene | 0.60 |
| T cells | expressed_in | cell_type | 0.60 |
| CRISPR-Cas | participates_in | pathway | 0.60 |
| AND | contributes_to | gene | 0.60 |
| TARDBP | inhibits | gene | 0.60 |
| oxidative stress response | participates_in | pathway | 0.60 |
| NEURON | regulates | gene | 0.60 |
| NEURODEGENERATIVE DISEASES | activates | gene | 0.60 |
| LYSOSOME | activates | gene | 0.60 |
| BECN1 | regulates | gene | 0.60 |
| ATG4B | inhibits | gene | 0.60 |
| CAT | inhibits | gene | 0.60 |
| CD19 | regulates | gene | 0.60 |
| Ras | activates | protein | 0.60 |
| Source | Relation | Type | Str |
|---|---|---|---|
| LC3B | expressed_in | gene | 0.70 |
| AUTOPHAGY | regulates | gene | 0.70 |
| AUTOPHAGY | expressed_in | gene | 0.70 |
| GENES | regulates | gene | 0.70 |
| ALS | regulates | gene | 0.60 |
| NEURODEGENERATIVE DISEASES | regulates | gene | 0.60 |
| LC3B | regulates | gene | 0.60 |
| AUTOPHAGY | activates | gene | 0.60 |
| LIPOPHAGY | activates | gene | 0.60 |
| FERROPTOSIS | activates | gene | 0.60 |
| CANCER | activates | gene | 0.60 |
| APOPTOSIS | regulates | gene | 0.60 |
| AUTOPHAGY-RELATED GENES | regulates | gene | 0.60 |
| TNF-Α | regulates | gene | 0.60 |
| CANCER | regulates | gene | 0.60 |
| INFLAMMATION | associated_with | gene | 0.60 |
| ROS | expressed_in | gene | 0.60 |
| NEURODEGENERATION | expressed_in | gene | 0.60 |
| OXIDATIVE STRESS | inhibits | gene | 0.60 |
| IL-6 | expressed_in | gene | 0.60 |
| ACHE | inhibits | gene | 0.60 |
| GENES | expressed_in | gene | 0.60 |
| AGING | inhibits | gene | 0.60 |
| GENES | therapeutic_target | gene | 0.60 |
| LC3B | therapeutic_target | gene | 0.60 |
| AUTOPHAGY | therapeutic_target | gene | 0.60 |
| ALS | therapeutic_target | gene | 0.60 |
| AMYOTROPHIC LATERAL SCLEROSIS | therapeutic_target | gene | 0.60 |
| MOTOR NEURONS | therapeutic_target | gene | 0.60 |
| NEURON | therapeutic_target | gene | 0.60 |
| AND | therapeutic_target | gene | 0.60 |
| BECN1 | associated_with | gene | 0.60 |
| CAT | therapeutic_target | gene | 0.60 |
| ATG4B | therapeutic_target | gene | 0.60 |
| TARDBP | therapeutic_target | gene | 0.60 |
| ATG13 | contributes_to | gene | 0.60 |
| ATG5 | contributes_to | gene | 0.60 |
| NCOA4 | activates | gene | 0.60 |
| ATG7 | contributes_to | gene | 0.60 |
| RAB7A | activates | gene | 0.60 |
| ATG4B | contributes_to | gene | 0.60 |
| CYCS | associated_with | gene | 0.60 |
| SOD1 | inhibits | gene | 0.60 |
| P62 | inhibits | gene | 0.60 |
| UBC | associated_with | gene | 0.60 |
| MTOR | activates | gene | 0.60 |
| ATG12 | regulates | gene | 0.60 |
| EIF2A | activates | gene | 0.60 |
| CAT | regulates | gene | 0.60 |
| FGF18 | expressed_in | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning ATG3 in their description or question text
No additional research found